Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Evome Medical Technologies Temettü

Temettü kriter kontrolleri 0/6

Evome Medical Technologies şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

Ödeme oranı

Sektör ortalama getirisi	1.7%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	CA$0.0299
Hisse başına kazanç	-CA$0.23
Temettü verim tahmini	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Jun 11

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: EVMT şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: EVMT şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Evome Medical Technologies Piyasaya Karşı Temettü Getirisi

EVMT temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (EVMT)	0%
Pazarın Alt %25'i (CA)	1.7%
Pazarın En İyi %25'i (CA)	5.8%
Sektör Ortalaması (Medical Equipment)	1.7%
Analist tahmini (EVMT) (3 yıla kadar)	n/a

Önemli Temettü: EVMT şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, EVMT şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: EVMT Canadian piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: EVMT herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Evome Medical Technologies Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Evome Medical Technologies Inc., Annual General Meeting, Nov 08, 2024

New major risk - Share price stability

High number of new and inexperienced directors

Riddell Sports Group, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. (TSXV:EVMT) for $3.6 million.

Evome Medical Technologies Inc. announced delayed annual 10-K filing

New major risk - Market cap size

Evome Medical Technologies Inc. Announces Board Changes

Evome Medical Technologies Inc. Announces Change of Principal Accounting Officer

New major risk - Revenue and earnings growth

Salona Global Medical Device Corporation Announces Leslie Cross Retires from its Board of Directors

Salona Global Medical Device Corporation Announces Resignation of Kyle L. Wilks as Board of Directors

Salona Global Medical Device Corporafion Announces the Debut of the Biodex Reac Five Step Trainer

Salona Global Medical Device Corporation Showcases Biodex Products at Medica Trade Fair in Dusseldorf, Germany; Expanding Access to International Markets

Salona Global Medical Device Corporation to Debut an Entire Next Generation Line of Products

New major risk - Market cap size

Salona Global Medical Device Corporation Announces Resignation of Dennis Nelson as Chief Accounting Officer and Treasurer

Salona Global Medical Device Corporation to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Financial position

Salona Global Medical Device Corporation Appoints Mike Seckler as Permanent CEO

Salona Global Medical Device Corporation, Annual General Meeting, Aug 11, 2023

Salona Global Appoints Michael Seckler, as Interim CEO

Salona Global Announces Appointment of Lana Newishy to Its Board of Directors as Executive Vice Chair

Salona Global Medical Device Corporation (TSXV:SGMD) acquired Arrowhead Medical, LLC for $0.85 million.

Salona Global Medical Device Corporation to Report Q1, 2023 Results on May 16, 2023

Price target decreased by 10.0% to CA$2.25

Salona Global Medical Device Corporation to Report Q3, 2023 Results on Jan 17, 2023

Salona Global Medical Device Corporation (TSXV:SGMD) entered into a binding agreement to acquire Physical medicine assets from Biodex Medical Systems, Inc for $8 million.

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Salona Global Medical Device Corporation Appoints Jane Kiernan as Director

Salona Global Medical Device Corporation Appoints Dennis Nelson as CFO

Salona Global Medical Device Corporation Announces Chief Executive Officer Changes

Salona Global Medical Device Corporation Appoints Luke Faulstick as CEO

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Salona Global Medical Device Corporation to Report Fiscal Year 2022 Results on May 31, 2022

Forecast to breakeven in 2023

High number of new and inexperienced directors

Salona Global Medical Device Corporation Announces Expansion of Mio-Guard Product Lines

Salona Global Medical Device Corporation (TSXV:SGMD) executed a binding definitive agreement to acquire Mio-Guard LLC from Ken Zisholz for $1.7 million.

Salona Global Medical Device Corporation announced that it has received CAD 4.26195 million in funding

Salona Global Medical Device Corporation announced that it expects to receive CAD 4.004 million in funding

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Salona Global Medical Device Corporation Provides Earnings Guidance for the Fiscal Year End February 28, 2022

Second quarter 2022 earnings released: CA$0.024 loss per share (vs CA$0.008 loss in 2Q 2021)

Here's Why We're Not Too Worried About Salona Global Medical Device's (CVE:SGMD) Cash Burn Situation

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin